Get startedLog in
    Picture of Reunion Neuroscience logo

    REUN — Reunion Neuroscience Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Reunion Neuroscience, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

    2018
    December 31st
    2019
    December 31st
    C2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-0.251-0.24-23.1-54.7-48.5
    Depreciation
    Non-Cash Items0.0430.0874.926.816
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital0.002-0.007-0.1390.0283.36
    Change in Accounts Receivable
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accrued Expenses
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-0.206-0.159-16.9-44.3-27.9
    Capital Expenditures——-1.65-2.98-0.232
    Purchase of Fixed Assets
    Other Investing Cash Flow Items0—-73.171.9-7.37
    Sale/Maturity of Investment
    Purchase of Investments
    Change in Net Intangibles
    Other Investing Cash Flow
    Cash from Investing Activities0—-74.768.9-7.61
    Financing Cash Flow Items-0.0020-7.020—
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities0.4980122-0.266-0.811
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash0.291-0.15930.224.6-36.8